Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.
J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):313-9. doi: 10.1016/j.jaip.2014.01.009. Epub 2014 Mar 29.
Patients with rhinitis often self-medicate with over-the-counter drugs, however this self-treating population has remained largely unstudied.
To characterize individuals self-medicating persistent rhinitis and to determine the prevalence of and risk factors for intranasal decongestant overuse within this population.
A cross-sectional observational study of individuals self-medicating persistent rhinitis (defined according to the Allergic Rhinitis and its Impact on Asthma guidelines). Participants (n = 895) completed a self-administered questionnaire to assess current symptoms, rhinitis medication, and previous physician diagnosis. Intranasal decongestant overuse was defined as daily use for at least 1 year.
The vast majority of subjects (95%) had moderate-to-severe rhinitis. Nasal congestion was the predominant symptom (median visual analog scale, 6.6 cm; interquartile range, 3.4 cm). Sixty-five percent had had their current nasal problems for more than 5 years. Approximately 80% had a physician diagnosis (mainly allergic rhinitis or rhinosinusitis). The prevalence of intranasal decongestant overuse was high (49%), despite the fact that most of the patients (80%) were educated about the limit on duration of use. Use of intranasal glucocorticosteroids was inversely related to being an overuser (odds ratio 0.24 [95% CI, 0.17-0.35]). The risk of intranasal decongestant overuse also was reduced by use of other medications (oral H1 antihistamines and decongestants), use of nasal saline solution, and more symptoms of itchy and/or runny eyes or colored mucus. Risk was increased by a more severely blocked nose, longer duration of symptoms, the presence of sleep disturbance, higher body mass index, and previous advice to limit the duration of intranasal decongestant use.
Half of the individuals self-medicating persistent rhinitis overused intranasal decongestants, despite the fact that they were educated about the limit on duration of use.
鼻炎患者常自行使用非处方药物,但对这一自疗人群的研究仍很少。
描述自行治疗持续性鼻炎的个体,并确定该人群中鼻内减充血剂过度使用的患病率和危险因素。
横断面观察性研究,纳入自行治疗持续性鼻炎(根据过敏性鼻炎及其对哮喘的影响指南定义)的个体。参与者(n=895)完成了一份自我管理问卷,以评估当前症状、鼻炎药物和以前的医生诊断。鼻内减充血剂过度使用定义为每天使用至少 1 年。
绝大多数患者(95%)有中重度鼻炎。鼻塞是主要症状(中位数视觉模拟量表为 6.6cm;四分位间距为 3.4cm)。65%的患者当前鼻部问题持续时间超过 5 年。约 80%的患者有医生诊断(主要为过敏性鼻炎或鼻-鼻窦炎)。尽管大多数患者(80%)都了解使用期限限制,但鼻内减充血剂过度使用的患病率仍很高(49%)。鼻内糖皮质激素的使用与过度使用者呈反比(比值比 0.24[95%置信区间,0.17-0.35])。使用其他药物(口服 H1 抗组胺药和减充血剂)、使用鼻腔盐水溶液、更多的眼睛瘙痒和/或流泪或有色黏液症状、更多的鼻部症状、更长的症状持续时间、存在睡眠障碍、更高的体重指数和之前建议限制鼻内减充血剂使用时间,均可降低鼻内减充血剂过度使用的风险。
尽管对使用期限限制进行了教育,但一半自行治疗持续性鼻炎的个体仍过度使用鼻内减充血剂。